title: Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes.
abstract: A series of polyoxometalates (POM) were synthesized and evaluated for anti-respiratory syncytial virus (RSV) activity. POM containing zirconium, tungsten, silicon, platinum, niobium or germanium of a variety of structural types have been evaluated. Sixteen of the compounds had very striking anti-RSV activity against a clinical isolate, Utah 89, with median effective concentration (EC50) values < or = 3 microM and selective indices > 80 as determined by viral cytopathic inhibition effect, neutral red uptake and virus yield reduction assays. The EC50 values for all three assays correlated very well (Pearson correlation coefficients > 0.90). POM containing sodium cations were totally inactive. Germanium-, niobium-, tin- and zirconium-containing compounds were found to be highly potent and selective. The antiviral activity was not cell line-dependent. The median cytotoxic concentration (IC50) values were generally greater than 100 microM. The compounds were also comparably active against a known laboratory RSV strain, A2, as well as other RSV strains. To detect any virus strain-specific inhibitory activity, seven POM were tested against other RSV strains; all were nearly equally inhibitory to the human virus strains, suggesting no strain specificity. Timing studies suggested that these compounds were most inhibitory during virus adsorption and penetration, although RSV was still significantly inhibited when the compound was added 3 h post-infection; which is considered well into the eclipse period. These data suggest that these potent, non-toxic compounds should be further studied as potential chemotherapeutic agents for treating RSV infections.
authors.affiliation: Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan 84322-5600, USA.
authors.forename: D L
authors.initials: DL
authors.lastname: Barnard
authors.forename: C L
authors.initials: CL
authors.lastname: Hill
authors.forename: T
authors.initials: T
authors.lastname: Gage
authors.forename: J E
authors.initials: JE
authors.lastname: Matheson
authors.forename: J H
authors.initials: JH
authors.lastname: Huffman
authors.forename: R W
authors.initials: RW
authors.lastname: Sidwell
authors.forename: M I
authors.initials: MI
authors.lastname: Otto
authors.forename: R F
authors.initials: RF
authors.lastname: Schinazi
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002417:Cattle; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D006801:Humans; D012136:Respiratory Syncytial Viruses / Q000187:drug effects* / Q000472:pathogenicity / Q000502:physiology; D014407:Tumor Cells, Cultured; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000998:Antiviral Agents